Guatemala Legal Hierarchy: Constitution, Health Code and Agreement 712-99

1. Key takeaways

The medical device regulatory framework in Guatemala is a five-level structure: the Constitution, then statute (the Health Code, Decreto 90-97), then regulations (the Acuerdos Gubernativos, with Agreement 712-99 at the core), then technical standards (NT — NT-37 v5-2016 for devices and NT-40 v3-2015 for reagents), and finally Central American technical regulations (RTCA) and international conventions. When making a compliance judgement, a lower-level instrument must not conflict with a higher-level one, and any conflict is resolved in favour of the higher level in the hierarchy. The point that matters most in practice is that the genuinely operational provisions sit almost entirely at the fourth level, in the technical standards, rather than in the statutes themselves. A team that reads only the Health Code and the two Gubernativo Agreements will understand the institutional design but will still not know what documents to compile, in what format, or with what validity period. For that reason, the practical reading order of any Guatemalan regulatory question runs in reverse: start from the NT that governs the product, fall back on 712-99 and 115-99 for the administrative powers, and reach the Constitution only when the competence of the authority itself is in doubt.

2. Legal basis

The table below maps each level of the hierarchy to its governing instrument, its number and date, and the provisions most often invoked in medical device and IVD work. The supporting standards listed alongside the two core NTs apply according to the matter concerned, so the same product may engage several of them across its lifecycle, from import licensing through renewal to market surveillance.

3. Expert insights

Insight one: the Health Code sets principles only; everything executable lives in the NT. Article 162 of the Health Code merely brings related products under sanitary regulation and imposes the registration obligation. What documents to submit, how many copies, and how long the registration remains valid are all defined by NT-37 and NT-40. A compliance plan that cites only the statutory level will produce no actionable conclusions at all, and reviewers who work from the statute alone will systematically underestimate the documentation burden.

Insight two: NT standards enter into force in an unusual way; the publication date is not a uniform effective date. Article 14 of NT-37 states that the standard takes effect from the day of publication on the department website, and NT-40 uses similar wording. This drafting does not pin the date to the calendar, so verification should rely on the current-text section of the MSPAS website rather than being back-calculated from the signature date. The practical consequence is that two dossiers prepared weeks apart may be judged against different NT versions if a revision is published in between, which is why the current-text check belongs in the pre-submission routine.

Insight three: an amending order can change market access conditions without changing the framework numbering. Acuerdo Gubernativo 104-2018 allows products approved by PAHO/WHO and seven other international regulatory agencies to proceed through a simplified review supported by a sworn declaration, yet the numbering and the framework of Agreement 712-99 were not replaced by it. After 2018, companies must still cite 712-99 as the foundation instrument of the regime.

Insight four: the RTCA and the NT operate in parallel, not as substitutes for each other. The RTCA harmonises dossier structure and regional requirements, while the NT sets the national acceptance details. Where the two conflict, judgement follows the current national NT and the legal hierarchy; the existence of an RTCA provision does not justify skipping the corresponding NT article. In file preparation this means the RTCA defines the skeleton of the dossier while the NT fills in the national particulars, and both must be satisfied before the submission is accepted.

4. Practical recommendations

• Build a ledger of the five levels of legal sources, recording for each instrument its name, number, publication or update date, wording on entry into force and applicable articles, and re-verify it quarterly.
• Resolve conflicts by following the order of Constitution, statute, regulation, technical standard, then regional regulation, and record the reasoning in the classification report.
• Flag NT version numbers separately and check whether a newer version has appeared on the MSPAS website before each submission.
• For post-market changes, check both NT Articles 6/7 and the classification criteria of Annex 1 of RTCA 11.03.59:18.
• When citing an amending order, state the instrument it amends, so that 104-2018 is not mistaken for a standalone regulation.

5. Verification checklist

• □ The list of legal sources at all five levels is complete
• □ Recorded 712-99 as dated 1999-09-17 and 115-99 as dated 1999-02-24
• □ Recorded the version numbers of NT-37 v5-2016 and NT-40 v3-2015
• □ Checked that the NT remains the current text on the MSPAS website
• □ Recorded the entry into force of RTCA 11.03.59:18 in Guatemala as 2022-01-03

Regulatory information verified as of 29 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Guatemalan market. Our team manages Ministry of Public Health and Social Assistance (MSPAS) registrations, coordinates import and distributor requirements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com